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Abstract
Background Orthopedic surgical-site infection (SSI),
mostly due to S. aureus, is recognized as a major adverse
event. This research aims to verify the usefulness of sur-
gical team decolonization in order to reduce the risk of
surgical-site infection.
Materials and methods We performed swabs of both
nares and oropharynx to identify S. aureus carriers among
orthopedic team members who consented to cooperate with
the study. Carriers were treated with local application of
mupirocin ointment.
Results Retrospective study of 1,000 consecutive patients
operated before surgical team decolonization showed 6%
SSIs. Of the 300 cases considered after decolonization,
none developed SSI.
Conclusions Though we are aware that more data need to
be collected, this work might be relevant for the intro-
duction of a new preventive protocol.
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Introduction
Surgical-site infections (SSIs) are a major adverse event
for patients and their surgeons. Orthopedic SSIs cause
substantial morbidity, prolonging hospital stay by a median
of 2 weeks, doubling rehospitalization rates, and more than
tripling overall healthcare costs [1]. Staphylococcus aureus
is the most important pathogen after surgical procedures,
and its nasal carriage is the main risk factor for SSI caused
by S. aureus [2], since carriers are two to nine times more
likely to acquire S. aureus SSIs than noncarriers [3]. The
mean carriage rate in the general population is 37.2% [3].
Several studies have been conducted on nasal decoloni-
zation in patients undergoing orthopedic surgery by using
perioperative intranasal mupirocin [4, 5], an attractive
prevention strategy, being a safe and simple method to
eradicate nasal colonization. Preoperative patient decolo-
nization signiﬁcantly decreases incidence of S. aureus
SSIs [4, 5]. Nevertheless, no experience is documented
regarding surgical team screening for S. aureus carriers
and the use of perioperative mupirocin for decolonization
in order to extend the prophylaxis against S. aureus
orthopedic SSIs. Therefore, the focus of this study is the
role of the surgical team as a possible risk factor for SSI
and to suggest a suitable and comprehensive protocol for
prevention.
Materials and methods
In order to establish the frequency of S. aureus nasal car-
riers among orthopedic surgical team members operating
within 2 m from the surgical site, we performed swabs of
both nares and oropharynx on 75 workers of the operating
theater (orthopedic surgeons, anesthesiologists and nurses)
who provided informed consent to be enrolled in the study.
Each collection swab was streaked onto S. aureus-
selective mannitol salt agar plates, incubated for 24 h at
37C, and examined for growth.
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daily nasal application of mupirocin ointment (Glaxo) for
5 days. The treatment was repeated 6 months later. Results
of mupirocin treatment were checked 3 months after
treatment by repeating swabs of both nares and
oropharynx.
SSIs in both pre- and posttreatment groups were diag-
nosed through wound swab and cultural examination in
presence of altered clinical and biohumoral parameters.
Results
Thirty out of 75 (40%) swabs resulted positive for presence
of S. aureus.
Susceptibility testing on the isolated bacteria indicated
that, while none of the carriers was mupirocin resistant,
23/30 produced b-lactamase (therefore being penicillin
resistant) and 5/30 were oxacillin resistant (Fig. 1).
Despite mupirocin application, one surgeon appeared
positive 3 months after treatment, and was therefore
excluded from the study.
In a second step of this study we compared the rate of
S. aureus SSIs in two series of patients operated before
(1,000 patients, retrospective analysis) and after (300
patients) decolonization of surgical teams.
All 75 team members, both carriers and noncarriers, had
to be considered because of the variable composition of the
surgical teams. Retrospective study on 1,000 consecutive
patients operated before nasal decolonization of the
surgical team showed 6% SSIs. Of the 300 cases consid-
ered after nasal decolonization, none developed SSI
(p = 0.439 Kruskall–Wallis test).
Operations were distributed as presented in Table 1. The
two considered groups are equivalent.
Discussion
This preliminary study shows for the ﬁrst time how a
prophylactic intervention on the surgical team can decrease
the SSI rate. Though we are aware that various problems
still have to be solved (such as intermittent carriers and
possible false negatives, the duration of decolonization
efﬁcacy and the appearance of resistance to treatment) and
that more data need to be collected to reinforce statistical
analysis, we consider this prophylactic approach to be
promising and worth being introduced into daily surgical
practice.
In accordance with published statistics [3], our work
conﬁrms the presence of 40% S. aureus carriers in surgical
teams, thus emphasizing the importance of decolonization
treatment not only for patients but—probably even more
strikingly—for health workers in the operating theater.
According to the CDC Guideline for Prevention of SSI,
healthcare organizations have to implement policies to
prevent transmission of microorganisms from personnel to
patients [6]. This work might be relevant for the develop-
ment of preventive protocols and guidelines for the intro-
duction of this kind of prophylaxis to reduce SSIs.
Fig. 1 Percentage of S. aureus
carriers in the screened
population of orthopedic
surgical team members (a) and
antibiotic resistance in the
isolated bacterial colonies (b)
Table 1 Distribution of
operations within the two
considered groups
Values are expressed as




Number Percentage (%) Number Percentage (%)
Hip-knee prosthesis 40 4 13 4.3
Shoulder-knee arthroscopy 515 51.5 167 55.7
Foot surgery 69 6.9 26 8.7
Hand surgery 210 21 67 22.3
Anterior cruciate ligament
reconstruction
61 6.1 20 6.7
Other 105 10.5 7 2.3
Total 1,000 300
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